Non-Hodgkin's Lymphoma Chronic Lymphoma Treatment Market: Evolving Care Pathways for Blood Cancers
Non-Hodgkin's lymphoma (NHL) encompasses a heterogeneous group of lymphoid malignancies that together represent one of the most commonly diagnosed blood cancers worldwide. The clinical course of NHL varies widely, from indolent forms that can be managed for years to aggressive subtypes requiring immediate and intensive intervention. This complexity has driven the Non-Hodgkin's Lymphoma...
0 Comments 0 Shares 28 Views 0 Reviews